|

ILKN421H Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • iLeukon Therapeutics, Inc.1

Indications

  • Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)1
  • Lung Cancer1
  • Cancer1

Los Angeles, California1 trial

ILKN421H Plus Pembrolizumab in Advanced Non-Small Cell Lung Cancer

Valkyrie Clinical Trials, Inc

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.